Abstracts tagged "Career and mentor"

Abstract Number: 1014 • 2015 ACR/ARHP Annual Meeting
Improvement in Mentoring Associated with Implementation of an Inter-Institutional Mentoring Program within Pediatric Rheumatology
Lakshmi N. Moorthy¹, Eyal Muscal², Meredith Riebschleger³, Marisa S. Klein-Gitelman⁴, Lise E. Nigrovic⁵, Kelly A. Rouster-Stevens⁶, Polly J. Ferguson⁷, B. Anne Eberhard⁸, Hermine I. Brunner⁹, Sampath Prahalad¹⁰, Rayfel Schneider¹¹ and Peter A. Nigrovic¹², ¹Pediatric Rheumatology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, ²Pediatric Rheumatology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, ³Pediatric Rheumatology & Health Services Research, University of Michigan, Ann Arbor, MI, ⁴Division of Rheumatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, ⁵Division of Emergency Medicine, Boston Children’s Hospital, Boston, MA, ⁶Pediatric Rheumatology, Emory Univ School of Medicine, Atlanta, GA, ⁷Dept of Pediatrics--Rheum, University of Iowa, Iowa City, IA, ⁸Schneider Children's Hospital, New Hyde Park, NY, ⁹Pediatric Rheumatology Collaborative Study Group, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ¹⁰Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, ¹¹Division of Rheumatology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, ¹²Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Mentoring is a key contributor to success in academic medicine. In pediatric rheumatology, surveys have repeatedly identified mentoring as a major career unmet need…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].